Global Elastomeric Infusion Pumps Market

Elastomeric Infusion Pumps Market Size, Share, Growth Analysis, By Product(Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application(Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, Others), By End-user(Hospitals, Ambulatory Surgical Centers, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2679 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 89 | Figures: 76

Elastomeric Infusion Pumps Market Competitive Landscape

The elastomeric infusion systems market exhibits a moderate level of fragmentation and competitiveness. Market players are actively engaged in strategies such as new product launches, collaborations, and innovations to strengthen their market presence and increase their share. These industry participants continually strive to introduce advanced solutions, forge strategic partnerships, and drive innovation, positioning themselves to capture a larger market share in the dynamic elastomeric infusion systems market.

Elastomeric Infusion Pumps Market Top Player’s Company Profiles

  • Baxter (US) 
  • Fresenius Kabi AG (Germany) 
  • B. Braun SE (Germany) 
  • Ambu A/S (Denmark) 
  • NIPRO (Japan) 
  • Terumo Corporation (Japan) 
  • AVNS (US) 
  • Vygon Group (France) 
  • Smiths Group plc (UK) 
  • ICU Medical, Inc. (US) 
  • Pajunk GmbH (Germany) 
  • Woo Young Medical Co., Ltd. (South Korea) 
  • Sapphire Medical (Israel) 
  • Ace Medical Co., Ltd. (South Korea) 
  • Eitan Medical (Israel) 
  • Zyno Medical (US) 
  • Epic Medical (Singapore) 
  • Nipro Corporation (Japan) 
  • Daiken Medical Co., Ltd. (Japan) 
  • Coopdech (Japan) 
  • Westmed, Inc. (US) 
  • Flowonix Medical Inc. (US)

Elastomeric Infusion Pumps Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Elastomeric Infusion Pumps Market size was valued at USD 638 million in 2022 and is poised to grow from USD 684.57 million in 2023 to USD 1202.87 million by 2031, growing at a CAGR of 7.30% during the forecast period (2024-2031).

The elastomeric infusion systems market exhibits a moderate level of fragmentation and competitiveness. Market players are actively engaged in strategies such as new product launches, collaborations, and innovations to strengthen their market presence and increase their share. These industry participants continually strive to introduce advanced solutions, forge strategic partnerships, and drive innovation, positioning themselves to capture a larger market share in the dynamic elastomeric infusion systems market. 'Baxter (US) ', 'Fresenius Kabi AG (Germany) ', 'B. Braun SE (Germany) ', 'Ambu A/S (Denmark) ', 'NIPRO (Japan) ', 'Terumo Corporation (Japan) ', 'AVNS (US) ', 'Vygon Group (France) ', 'Smiths Group plc (UK) ', 'ICU Medical, Inc. (US) ', 'Pajunk GmbH (Germany) ', 'Woo Young Medical Co., Ltd. (South Korea) ', 'Sapphire Medical (Israel) ', 'Ace Medical Co., Ltd. (South Korea) ', 'Eitan Medical (Israel) ', 'Zyno Medical (US) ', 'Epic Medical (Singapore) ', 'Nipro Corporation (Japan) ', 'Daiken Medical Co., Ltd. (Japan) ', 'Coopdech (Japan) ', 'Westmed, Inc. (US) ', 'Flowonix Medical Inc. (US)'

The rising incidence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver for the elastomeric infusion pumps market. These pumps provide a reliable and convenient method of delivering medications for long-term management of chronic conditions.

There was a growing trend towards home healthcare and ambulatory care, driven by factors such as the rising elderly population, preference for cost-effective treatment options, and advancements in medical technology. Elastomeric infusion pumps were being increasingly utilized in homecare settings due to their ease of use, portability, and ability to provide continuous infusion of medications without the need for electronic programming. This trend allowed patients to receive treatment outside of traditional healthcare facilities, promoting patient comfort and reducing the burden on healthcare facilities.

In the global elastomeric infusion pumps market, regional insights reveal a dynamic landscape driven by various factors across different regions. North America emerges as the largest market segment, primarily due to the region's advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological advancements. The increasing prevalence of chronic diseases, rising demand for pain management solutions, and extensive adoption of elastomeric infusion pumps contribute to the dominance of North America in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Infusion Pump Market
Buy Now GET FREE SAMPLE
Intravenous Infusion Pump Market
Buy Now GET FREE SAMPLE
Turbomolecular Pumps Market
Buy Now GET FREE SAMPLE
Electric Breast Pumps Market
Buy Now GET FREE SAMPLE
Wearable Breast Pumps Market
Buy Now GET FREE SAMPLE
Industrial Pumps Market
Buy Now GET FREE SAMPLE
Heavy-duty Pumps Market
Buy Now GET FREE SAMPLE
Pressure Pumping Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Elastomeric Infusion Pumps Market

Report ID: SQMIG35A2679

$5,300
BUY NOW GET FREE SAMPLE